India has suspended a drugmaker’s manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday. Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.
Recent Posts
- India to pursue Seafarers’ Emergency Support Network, confident of global backing: MEA
- “I think that will happen”: OpenAI CEO Sam Altman hints at safety pact with other AI companies
- Iran, Oman agree on new entry, exit routes for Strait of Hormuz: Report
- “Exponential growth of AI a warning sign”: Anthropic CEO Dario Amodei continues push for AI safeguards
- National Lok Adalat gives compensation of Rs 2.4 cr to kin of banker killed in Navi Mumbai accident
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits